AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 82 min read$MCK

TYLER BRIAN S. sold $6.7M of MCK

TYLER BRIAN S. (Chief Executive Officer) sold 8,463 shares of MCKESSON CORP (MCK) at $793.56 ($6.72M total) on 2026-07-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · TYLER BRIAN S.
Published Jul 8, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$MCK
Neutral
medium confidence
Mentioned
$MCK
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MCKNeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but 10b5-1 plans generally limit the informational content about near-term business performance.

02

Market read

A CEO open-market sale of about $6.72M in McKesson shares was reported, but it is scheduled under a 10b5-1 plan.

03

What to watch

The filing does not disclose reasons for the sale, and 10b5-1 schedules can be triggered regardless of current fundamentals or sentiment.

Relevance 5/10Novelty 5/10Timing: SEC Form 4 filed 2026-07-08 for a 2026-07-07 insider sale.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for McKesson (MCK).

Company-level read

Ticker impact

$MCKNeutralMedium confidence
Context

McKesson CEO Tyler Brian S. filed a Form 4 selling 8,463 shares at $793.56 for about $6.72M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this filing; any impact is likely short-lived.

Evidence & confidence

The transaction is an open-market sale by the CEO, explicitly under a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Sector

Minimal sector read-through; this is company-specific insider transaction data.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A large CEO sale can be interpreted as confidence in liquidity needs or diversification rather than negative outlook, especially with a 10b5-1 plan.

Key entities

  • issuer
    MCKESSON CORP

    Company whose CEO insider sale is disclosed on Form 4.

  • insider
    TYLER BRIAN S.

    McKesson CEO and director who sold shares.

  • trading mechanism
    Rule 10b5-1 plan

    Pre-arranged plan that typically reduces interpretive weight of insider sales.

Read at source← All news

Related articles

AUG 8
$MCKMed

McKesson Q1 Earnings Call Highlights

McKesson (NYSE: MCK) reported Q1 results supported by higher prescription and specialty volumes, partially offset by lower branded-drug pricing. GLP-1 distribution revenue rose to $15B, up about $3B (24%). Full-year guidance calls for North American Pharmaceutical revenue growth of 4% to 8%. Oncology & Multispecialty profit rose 41% to $405M. McKesson repurchased $2.5B shares and expects FY27 FCF $4.5B to $4.9B.

finance.yahoo.com6 min
AUG 6
$MCKMedAI 8/10

Highlights of McKesson’s (MCK) Q1 2027 earnings report

McKesson (MCK) reported Q1 fiscal 2027 results. Adjusted earnings rose to $9.93 per share from $8.26 a year earlier, beating analysts. Unadjusted net income was $614 million, or $5.17 per share. Revenue increased to $105.4 billion from $97.83 billion. The company raised FY27 adjusted EPS guidance to $44.20 to $45.00.

news.alphastreet.com2 min
AUG 5
$MCKHighAI 9/10

[MCK Q1 2027 Earnings Call] McKesson Lifts Full-Year EPS Target as North American Pharma Profit Soars 19% — BigGo Finance

McKesson reported fiscal Q1 2027 revenue of $105.4B, up 8%, and adjusted EPS of $9.93, up 20%, citing stronger North American Pharmaceutical margins. North American Pharma operating profit rose 19% to $894M on 5% revenue growth, with GLP-1 distribution revenue at $15B (+24%). McKesson raised full-year adjusted EPS guidance to $44.20–$45.00 and returned $2.6B to shareholders.

finance.biggo.com4 min